ArticleJournal for immunotherapy of cancer2022

Vδ2 T cells are associated with favorable clinical outcomes in patients with bladder cancer and their tumor reactivity can be boosted by BCG and zoledronate treatments.

Sylvain Nguyen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.